Find the latest news from Novozymes' news archive.
28 May 2015
The companies will develop a product based on naturally occurring microbes that can reduce antibiotic usage in poultry and brings associated health benefits.
20 May 2015
UN FAO, Roundtable on Sustainable Biomaterials, Bloomberg New Energy Finance, Carbon War Room, KLM, Novozymes and the UN Foundation partner to scale up the development and deployment of sustainable bioenergy solutions.
19 May 2015
Building on Novozymes Biopharma’s recombinant human albumin, Recombumin®, Serendex Pharmaceutical’s leading drug candidate has now entered clinical trials.
05 May 2015
The world’s first facility to produce cellulosic ethanol from sawdust will use Novozymes’ customized enzymes. With an annual capacity of 10 million liters, the plant represents an expected investment of around €40 million.
23 April 2015
Today the company raised its sales and earnings outlook for 2015 due to U.S. dollar appreciation. Currency developments in the first three months of the year have boosted Novozymes’ results. But the strength of the dollar can also have a downside.
Q1 in line with expectations; 2015 outlook adjusted for currencies
27 March 2015
Pursuant to company announcement no. 11, 2015, a reduction of the company’s B common stock by DKK 13,400,000 via cancellation of 6,700,000 treasury B stocks was adopted at the Annual Shareholders’ Meeting of Novozymes A/S on February 25, 2015.
25 March 2015
Novozymes Secura® simplifies starch processing while enabling significant chemical and energy savings.
25 February 2015
Today Novozymes A/S held its Annual Shareholders’ Meeting.
29 January 2015
On February 2, 2015, Novozymes will initiate a stock buyback program as announced in Company announcement No. 1 of January 20, 2015.
| Copyright © 2015 Novozymes. All Rights Reserved.